Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

C.R. Bard (BCR)

C.R. Bard (BCR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 24,144,082
  • Shares Outstanding, K 72,890
  • Annual Sales, $ 3,714 M
  • Annual Income, $ 531,400 K
  • 60-Month Beta 0.52
  • Price/Sales 6.54
  • Price/Cash Flow N/A
  • Price/Book 11.97
Trade BCR with:
  • Price/Earnings ttm 28.77
  • Earnings Per Share ttm 11.58
  • Most Recent Earnings 3.02 on 10/25/17
  • Next Earnings Date 01/25/18
  • Annual Dividend & Yield 0.78 (0.00%)
  • Most Recent Dividend 0.260 on 07/20/17
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/17
See More
  • Average Estimate 3.09
  • Number of Estimates 5
  • High Estimate 3.10
  • Low Estimate 3.08
  • Prior Year 2.77
  • Growth Rate Est. (year over year) +11.55%

Price Performance

See More
Period Period Low Period High Performance
1-Month
330.68 +0.17%
on 12/22/17
337.73 -1.92%
on 12/01/17
-5.19 (-1.54%)
since 11/28/17
3-Month
319.02 +3.83%
on 09/29/17
337.73 -1.92%
on 12/01/17
+11.86 (+3.71%)
since 09/28/17
52-Week
222.42 +48.93%
on 12/29/16
337.73 -1.92%
on 12/01/17
+108.79 (+48.91%)
since 12/28/16

Most Recent Stories

More News
Worldwide Hernia Repair Devices and Consumables Industry to 2028 - by Hernia Type, Surgery Type, Component and Region

, /PRNewswire/ -- The report has been added to offering.

AGN : 193.02 (+0.02%)
BAX : 84.79 (+0.30%)
BCR : 331.24 (-0.59%)
MDT : 123.63 (+1.51%)
Next Generation Implants Market to Reach Value of USD 4.45 Billion by 2028 | Technological Advancements in Medical Implants In Skin Tissue And Bone will be the Key Factor Driving the Industry Growth, States Emergen Research

The global next generation implants (NGI) market size was USD 3.43 Billion in 2020 and is expected to reach a market size of USD 4.45 Billion in 2028 and register a steady CAGR of 3.2%, over the forecast...

ABT : 123.01 (+1.63%)
BSX : 39.41 (+0.18%)
BCR : 331.24 (-0.59%)
GMED : 67.62 (+0.07%)
MDT : 123.63 (+1.51%)
SNN : 38.80 (+0.65%)
SYK : 253.57 (+0.69%)
WMGIZ : 0.01 (unch)
Global Breast Biopsy Devices -Segment Analysis, Opportunity Assessment, Competitive Intelligence, Industry Outlook 2018-2026

BCR : 331.24 (-0.59%)
HOLX : 75.65 (+1.65%)
LivaNova Announces Board Appointment and Board Leadership Changes

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced a series of enhancements to the Company's governance.

BCR : 331.24 (-0.59%)
SPNC : 38.45 (unch)
THOR : 67.99 (unch)
LIVN : 82.05 (+1.30%)
Breast Cancer Diagnostics Market to Reach USD 8,738.9 Million By 2027 | Reports And Data

Growing awareness for early detection of breast cancer is one of the significant factors influencing the market growth.

BCR : 331.24 (-0.59%)
GHDX : 63.44 (-0.69%)
HOLX : 75.65 (+1.65%)
NSTG : 74.56 (+8.00%)
Company to pay $60M for deceptive marketing with pelvic mesh

JACKSON, Miss. (AP) — A company that failed to adequately inform women of dangerous side effects related to permanent pelvic mesh devices will be required to pay $60 million, according to a settlement...

JNJ : 159.48 (-1.34%)
BCR : 331.24 (-0.59%)
Kidney Stone Management Market to Hit USD 2.21 Billion by 2027 with 5.3% CAGR: Popularity of Miniaturized Surgeries to Boost Growth, says Fortune Business Insights(TM)

Global kidney stone management market size is expected to rise prominently on account of the increasing cases of kidney stone among people worldwide. This is further attributed to the formation of crystal-like...

BSX : 39.41 (+0.18%)
BCR : 331.24 (-0.59%)
OCPNY : 21.2900 (+1.62%)
The Global Radiation Oncology Market is expected to grow from USD 9,823.13 Million in 2018 to USD 14,675.13 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 5.90%

Reportlinker.com announces the release of the report "Global Radiation Oncology Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025"...

BCR : 331.24 (-0.59%)
EKTAF : 13.5500 (+3.44%)
ISR : 1.0400 (+2.97%)
VAR : 177.11 (-0.01%)
The Global Surgical Mesh Market is expected to grow from USD 2,595.17 Million in 2018 to USD 4,017.49 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 6.44%

Reportlinker.com announces the release of the report "Global Surgical Mesh Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025" - https://www.reportlinker.com/p05871785/?utm_source=GNW...

BCR : 331.24 (-0.59%)
Pulmonx Names Industry Veteran to Board of Directors

Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, today announced that Daniel Florin has joined its Board...

BCR : 331.24 (-0.59%)
ZBH : 168.47 (+0.08%)

Business Summary

C. R. Bard, Inc., together with its subsidiaries, designs, manufactures, packages, distributes, and sells medical, surgical, diagnostic, and patient care devices worldwide. The company offers vascular products, such as percutaneous transluminal angioplasty catheters, chronic total occlusion catheters,...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 334.96
1st Resistance Point 333.10
Last Price 331.24
1st Support Level 330.31
2nd Support Level 329.38
3rd Support Level N/A

See More

52-Week High 337.73
Last Price 331.24
Fibonacci 61.8% 293.68
Fibonacci 50% 280.08
Fibonacci 38.2% 266.47
52-Week Low 222.42

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar